Skip to content

Clinical trials

Completed Primary Myelofibrosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Status: Completed Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20061
20091
20101
20113
20121
20135
20144
20153
20161
20172
20181
20191
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Sierra Oncology LLC - a GSK company4
European Organisation for Research and Treatment of Cancer - EORTC3
CTI BioPharma2
Celgene2
Hoffmann-La Roche2
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2
Incyte Corporation2
AbbVie1
Constellation Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis34
Myeloproliferative Disorders9
Polycythemia Vera9
Thrombocythemia, Essential9
Neoplasms5
Hematologic Diseases4
Leukemia, Myeloid, Acute4
Anemia3
Blast Crisis3
Bone Marrow Diseases3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.